reports
- Sumeet Singh
MicroPort MedBot IPO
aims to raise up to US$200m in its Hong Kong IPO. MicroPort MedBot (MM) is a surgical robot company which designs, develops and commercializes surgical robots to assist surgeons in performing complex surgical procedures. It is the only company with a product portfolio covering the five major and fast-growing surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures, as per Frost & Sullivan (F&S). We have looked at the company’s backgrou...
- Zhen Zhou Toh
- Sumeet Singh
MicroPort MedBot Pre-IPO
Shanghai MicroPort MedBot Group (MM), a surgical robot company, aims to raise up to US$1bn in its Hong Kong IPO. MicroPort MedBot (MM) is a surgical robot company which designs, develops and commercializes surgical robots to assist surgeons in performing complex surgical procedures. It is the only company with a product portfolio covering the five major and fast-growing surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures, as per Fr...
- Sumeet Singh
MicroPort MedBot Pre-IPO
Shanghai MicroPort MedBot Group (MM), a surgical robot company, aims to raise up to US$1bn in its Hong Kong IPO. MicroPort MedBot (MM) is a surgical robot company which designs, develops and commercializes surgical robots to assist surgeons in performing complex surgical procedures. It is the only company with a product portfolio covering the five major and fast-growing surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures, as per Fr...
- Sumeet Singh
MicroPort MedBot Pre-IPO
Shanghai MicroPort MedBot Group (MM), a surgical robot company, aims to raise up to US$1bn in its Hong Kong IPO. MicroPort MedBot (MM) is a surgical robot company which designs, develops and commercializes surgical robots to assist surgeons in performing complex surgical procedures. It is the only company with a product portfolio covering the five major and fast-growing surgical specialties of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures, as per Fr...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.